
Sabiha Naim Qazi
Examiner (ID: 9181)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1612, 1627, 1629, 1611, 1616, 1628, 1621, 1202 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10489701
[patent_doc_number] => 20150374722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration'
[patent_app_type] => utility
[patent_app_number] => 14/844998
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8843
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/844998 | Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration | Sep 2, 2015 | Abandoned |
Array
(
[id] => 11977490
[patent_doc_number] => 20170281641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/508738
[patent_app_country] => US
[patent_app_date] => 2015-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94345
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508738 | CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS | Sep 1, 2015 | Abandoned |
Array
(
[id] => 11942036
[patent_doc_number] => 20170246187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => '(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 15/507754
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 22792
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507754
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507754 | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | Aug 27, 2015 | Abandoned |
Array
(
[id] => 10706812
[patent_doc_number] => 20160052959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'RADIOLABELED CATIONIC STEROID ANTIMICROBIALS AND DIAGNOSTIC METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/830356
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15810
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14830356
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/830356 | Radiolabeled cationic steroid antimicrobials and diagnostic methods | Aug 18, 2015 | Issued |
Array
(
[id] => 10705537
[patent_doc_number] => 20160051683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'EXCIPIENT COMPOSITIONS FOR MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS INCLUDING A SYNERGISTIC COMBINATION OF AMYLOPECTIN, PULLULAN, HYALURONIC ACID, AND XYLOGLUCAN'
[patent_app_type] => utility
[patent_app_number] => 14/830418
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6196
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14830418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/830418 | Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan | Aug 18, 2015 | Issued |
Array
(
[id] => 11962015
[patent_doc_number] => 20170266169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 15/503643
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12266
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503643 | CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN | Aug 13, 2015 | Abandoned |
Array
(
[id] => 10450631
[patent_doc_number] => 20150335645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Combination of BRAF and VEGF Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/811881
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15639
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14811881
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/811881 | Combination of BRAF and VEGF Inhibitors | Jul 28, 2015 | Abandoned |
Array
(
[id] => 10812091
[patent_doc_number] => 20160158251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'COMPOSITION FOR PREVENTING OR TREATING MUSCULAR ATROPHY OR PROMOTING MUSCULAR REGENERATION IN SUBJECT COMPRISING SULFONAMIDE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/812705
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4498
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812705
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812705 | COMPOSITION FOR PREVENTING OR TREATING MUSCULAR ATROPHY OR PROMOTING MUSCULAR REGENERATION IN SUBJECT COMPRISING SULFONAMIDE COMPOUND AND USE THEREOF | Jul 28, 2015 | Abandoned |
Array
(
[id] => 11217277
[patent_doc_number] => 09445593
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-09-20
[patent_title] => 'Arthropodicidal anthranilamides'
[patent_app_type] => utility
[patent_app_number] => 14/799816
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33719
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14799816
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/799816 | Arthropodicidal anthranilamides | Jul 14, 2015 | Issued |
Array
(
[id] => 11797959
[patent_doc_number] => 09491945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Synergistic microbicidal combinations'
[patent_app_type] => utility
[patent_app_number] => 14/796190
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796190 | Synergistic microbicidal combinations | Jul 9, 2015 | Issued |
Array
(
[id] => 10428218
[patent_doc_number] => 20150313230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'Synergistic Microbicidal Combinations'
[patent_app_type] => utility
[patent_app_number] => 14/795997
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795997
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795997 | Synergistic microbicidal combinations | Jul 9, 2015 | Issued |
Array
(
[id] => 11282133
[patent_doc_number] => 09497968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Synergistic microbicidal combinations'
[patent_app_type] => utility
[patent_app_number] => 14/796285
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796285
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796285 | Synergistic microbicidal combinations | Jul 9, 2015 | Issued |
Array
(
[id] => 11282134
[patent_doc_number] => 09497969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Synergistic microbicidal combinations'
[patent_app_type] => utility
[patent_app_number] => 14/796397
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796397 | Synergistic microbicidal combinations | Jul 9, 2015 | Issued |
Array
(
[id] => 11248802
[patent_doc_number] => 09474280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Synergistic microbicidal combinations'
[patent_app_type] => utility
[patent_app_number] => 14/796079
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796079
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796079 | Synergistic microbicidal combinations | Jul 9, 2015 | Issued |
Array
(
[id] => 10654665
[patent_doc_number] => 20160000808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/794416
[patent_app_country] => US
[patent_app_date] => 2015-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20885
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14794416
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/794416 | Androgen receptor down-regulating agents and uses thereof | Jul 7, 2015 | Issued |
Array
(
[id] => 10435723
[patent_doc_number] => 20150320735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'METHOD FOR TREATING/PREVENTING DISEASE USING COGNITIVE ABILITY OF CEREBRUM AND PHARMACEUTICAL'
[patent_app_type] => utility
[patent_app_number] => 14/788358
[patent_app_country] => US
[patent_app_date] => 2015-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14591
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14788358
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/788358 | Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical | Jun 29, 2015 | Issued |
Array
(
[id] => 10474785
[patent_doc_number] => 20150359802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'PARENTERAL PHARMACEUTICAL FORM WHICH RELEASES AROMATSE INHIBITOR AND GESTAGENS, FOR THE TREATMENT OF ENDOMETRIOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/743935
[patent_app_country] => US
[patent_app_date] => 2015-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8901
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743935
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/743935 | PARENTERAL PHARMACEUTICAL FORM WHICH RELEASES AROMATSE INHIBITOR AND GESTAGENS, FOR THE TREATMENT OF ENDOMETRIOSIS | Jun 17, 2015 | Abandoned |
Array
(
[id] => 10476487
[patent_doc_number] => 20150361504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'BIOMARKER FOR PREDICTING RESPONSE OF CLL TO TREATMENT WITH A BTK INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/738617
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26040
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14738617
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/738617 | BIOMARKER FOR PREDICTING RESPONSE OF CLL TO TREATMENT WITH A BTK INHIBITOR | Jun 11, 2015 | Abandoned |
Array
(
[id] => 11336687
[patent_doc_number] => 20160362442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'Method For DHEA Enanthate Processing'
[patent_app_type] => utility
[patent_app_number] => 14/736103
[patent_app_country] => US
[patent_app_date] => 2015-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3008
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736103
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/736103 | Method For DHEA Enanthate Processing | Jun 9, 2015 | Abandoned |
Array
(
[id] => 10380628
[patent_doc_number] => 20150265635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => '9-SUBSTITUTED MINOCYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/732350
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10961
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732350
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732350 | 9-SUBSTITUTED MINOCYCLINE COMPOUNDS | Jun 4, 2015 | Abandoned |